* Sanara Medtech Inc SMTI.OQ SMTI.O is expected to show
a rise
in quarterly revenue when it reports results on May 13 for the
period ending March 31 2024
* The Fort Worth Texas-based company is expected to report
a
19.2% increase in revenue to $18.5 million from $15.52 million a
year ago, according to the estimate from one analyst, based on
LSEG data.
* LSEG's mean analyst estimate for Sanara Medtech Inc is
for a
loss of 7 cents per share.
* The one available analyst rating on the shares is "buy".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Sanara
Medtech
Inc is $44.00, above its last closing price of $31.42.
This summary was machine generated May 10 at 22:44 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)